A Study to Assess the Safety of a Self-Amplifying RNA Vaccine Against Influenza in Healthy Participants
A Phase 1, Placebo-Controlled, Randomized, Observer-Blind, Dose Finding Study to Evaluate the Safety, Tolerability, and Immunogenicity of Self-Amplifying RNA Vaccine Preparations Against Influenza in Healthy Individuals
Category & Conditions: Infections and Infectious Diseases
Medicine: PF-07845104 (Influenza saRNA Vaccine)
ClinicalTrials.gov Identifier (NCT): NCT05227001
Protocol ID: C4861001
Open Plain Language Summary Result:
Click here